Fingerprint
Dive into the research topics of 'Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann M. Brown, Shaker R. Dakhil
Research output: Contribution to journal › Article › peer-review
4244
Scopus
citations